ULCERATIVE colitisINFLAMMATORY bowel diseasesBIOLOGICALSSURGICAL excisionREGRESSION analysisDEEP brain stimulationDISEASE exacerbationTo gain abetter understanding of the effects of biologics, we evaluated clinical outcomes in patients with moderate to severe exacerbations of ulcerative colitis (UC). This ...
Ulcerative colitis is characterized by chronic inflammation of the colon. Typical symptoms are diarrhoea, rectal bleeding, abdominal pain and fever. The aetiology of the disease is unclear. The inflammation can be localized in the rectum or can extend to the left side or the whole colon. Treatmen...
The present study evaluates the long-term (2 years) effects of combination therapy (mesalazine plus a probiotic blend of Lactobacillus salivarius, Lactobacillus acidophilus and Bifidobacterium bifidus strain BGN4) on ulcerative colitis activity.Method: Sixty patients with moderate-to-severe ulcerative ...
To study the long-term effects of restorative proctocolectomy with J-pouch for ulcerative colitis 100 consecutive patients were examined a mean of 5.6 years after ileal pouch-anal anastomosis (IPAA). Seventythree percent of patients were on steroids and 22% had a preceding severe attack of colit...
Long- term treatment of ulcerative colitis with ciprofloxacin: a pro- spective, double-blind, placebo-controlled study. Gastroen- terology 1998; 115: 1072-1078Turunen UM, Farkkila MA, Hakala K, et al. : Longterm treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind,...
Targeting the interlieukin-23 pathway with mirikizumab, a p19-directed IL-23 antibody, may be an effective option for maintenance therapy in ulcerative colitis, according to research presented at the Congress of the European Crohn’s...
Effects of long-chain omega-3 (LCn3) and omega-6 fatty acids on prevention and treatment of inflammatory bowel diseases (IBD, including Crohn’s Disease, CD and ulcerative colitis, UC), and inflammation are unclear. We systematically reviewed long-term effects of omega-3, omega-6 and total...
Background and AimUlcerative colitis (UC) is a chronic inflammatory bowel disease that is characterized by periods of remission and episodes of relapse. Mucosal healing is an emerging therapeutic target in UC and various scoring systems have been used. The UC endoscopic index of severity (UCEIS) ...
The effect of ulcerative colitis (UC) remission status aft er induction with MMX mesalamine on long-term maintenance therapy outcomes (momentum study): Induction phase results presidential posterD., RubinG., D'HaensS., InglisE., MageeD., Solomon...
Twenty-five patients with ulcerative colitis considered "failures of therapy with adrenal steroids and salicylazosulfapyridine" but without absolute indication for surgical intervention were treated with 6-mercaptopurine. The dose ranged from 50 to 200 mg daily and the period of treatment from 10 to ...